Originally acquired by Eli Lilly , oritavancin was discovered and developed by InterMune in 2001 and then by Targanta Therapeutics in late 2005 .
Originally taken over by Eli Lilly , oritavancin was discovered and developed in 2001 by InterMune and in late 2005 by Targanta Therapeutics .